Used in research and development of diagnostic tools and therapeutic agents targeting amyloid-beta plaques, which are associated with Alzheimer's disease. This antibody serves as a reference standard in immunoassays to detect and quantify amyloid-beta peptides in biological samples. It is also employed in preclinical studies to evaluate the efficacy of new anti-amyloid compounds and in immunohistochemistry to visualize plaque deposition in brain tissue. Due to its well-characterized specificity, it supports consistency and reproducibility in Alzheimer’s disease research and drug development.